CARDIOFLOW-B: DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OF THE TARGET COMPANY AND NOTICE OF EXTRAORDINARY GENERAL MEETING
CARDIOFLOW-B: DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATIONTO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OFTHE TARGET COMPANY
CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTIONIN RELATION TOTHE 2024 KEWEI DISTRIBUTION FRAMEWORK AGREEMENTANDCONNECTED TRANSACTIONIN RELATION TO THE KEWEI LOAN AGREEMENT
CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTIONIN RELATION TO2024 MP CARDIOADVENT SERVICE PROCUREMENT FRAMEWORKAGREEMENT
CARDIOFLOW-B: CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 51% EQUITY INTEREST IN MP CARDIOADVENT AND CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
CARDIOFLOW-B: (1) RENEWAL OF EXISTING CONTINUING CONNECTED TRANSACTIONS (2) CONTINUING CONNECTED TRANSACTION IN RELATION TO 2023 DISTRIBUTION FRAMEWORK AGREEMENT AND (3) NOTICE OF EXTRAORDINARY GENERAL MEETING
CARDIOFLOW-B: CONNECTED TRANSACTION - ASSETS TRANSFER AGREEMENT
CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTIONS
CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTION IN RELATION TO 2022 EQUIPMENT PROCUREMENT FRAMEWORK AGREEMENT
CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTION IN RELATION TO 2022 SERVICE PROCUREMENT FRAMEWORK AGREEMENT
CARDIOFLOW-B: FURTHER ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION - LEASING OF PROPERTIES
CARDIOFLOW-B: CONNECTED TRANSACTION - PROPOSED FORMATION OF JOINT VENTURE
CARDIOFLOW-B: DISCLOSEABLE TRANSACTION - LEASING OF THE PROPERTY
No Data